5th IOF Asia-Pacific Osteoporosis Meeting opens in Taipei

November 14, 2014

Today, researchers and clinicians from throughout the region have gathered in Taipei for the opening of the 5th Asia-Pacific Osteoporosis Meeting. The event, taking place from November 14 to 16, is one of the Asia-Pacific's most important bone, muscle and joint congresses. It has been organized by the International Osteoporosis Foundation (IOF) in cooperation with the Taiwanese Osteoporosis Association (TOA).

Osteoporosis is often termed the 'silent disease' because there are no apparent symptoms until a patient suffers a broken bone - as a result the majority of people with osteoporosis often remain undiagnosed and untreated. Speaking at the opening of the Congress, Mr. Sun Yueh, an 84-year old Taiwanese retired actor and full-time volunteer who has been diagnosed with osteoporosis, recounted his personal story. Mr. Yueh reminded delegates that by ensuring the early diagnosis of osteoporosis and its appropriate management, they are helping their patients avoid a potential cascade of painful fractures and long-term disability.

Professor Rong-Sen Yang, co-chair of the Meeting, said, "The Scientific Programme Committee has planned an extraordinary programme which features both advances in clinical practice and the latest regional research in the field. Delegates will hear about many exciting new developments and will have the opportunity to meet leading researchers and clinicians from around the world."

Taiwanese Osteoporosis Association President, Prof. Fang-Ping Chen, stated, "With osteoporosis acknowledged as a serious and growing health problem in Asia, we are very pleased to join IOF in hosting this important meeting in Taipei. We believe that as a result of the high quality scientific programme, delegates will return home with valuable new knowledge and insights to help them to better prevent and treat osteoporotic fractures in their patients."

IOF Regionals 5th Asia-Pacific Osteoporosis Meeting

Organized by IOF and the Taiwanese Osteoporosis Foundation, the 5th Asia-Pacific Osteoporosis Meeting is being held in Taipei from November 14-16, 2014 at the Taipei International Convention Centre. The IOF Regionals have been a key educational and research forum in the Asia-Pacific region since 2010. Past Meetings have been held in Hong Kong, Kuala Lumpur, Australia, and Singapore. The 6th IOF Regionals Asia-Pacific Meeting is planned in Singapore in November 2016.

For information about these and other IOF congresses and training visit http://www.iofbonehealth.org/upcoming-events
About IOF

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers, leading companies, as well as more than 200 patient, medical and research societies, work together to make bone, joint and muscle health a worldwide heath care priority. http://www.iofbonehealth.org / http://www.facebook.com/iofbonehealth / https://twitter.com/iofbonehealth

International Osteoporosis Foundation

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.